Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
12/23/1998 | WO1998057629A1 Composition for controlling mood disorders in healthy individuals |
12/23/1998 | EP0885960A2 G-protein coupled receptor (H7TBA62) |
12/23/1998 | EP0885959A2 Human Wnt-5b protein |
12/23/1998 | EP0885904A1 Peptides as agonists and/or inhibitors of amyloid formation and/or cytotoxicity and their use against Alzheimer's disease, type II diabetes mellitus and spongiform encephalopathy |
12/23/1998 | EP0885891A1 Isoxazole derivatives |
12/23/1998 | EP0885608A1 Remedies for brain diseases |
12/23/1998 | EP0885309A1 Direct molecular diagnosis of friedreich ataxia |
12/23/1998 | EP0885229A1 Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon |
12/23/1998 | EP0885221A1 Azabicyclic esters of carbamic acids useful in therapy |
12/23/1998 | EP0885220A1 Tropane-derivatives, their preparation and use |
12/23/1998 | EP0885218A1 Oxa- and thia-diazole muscarinic receptor antagonists |
12/23/1998 | EP0885217A1 Endothelin receptor antagonists |
12/23/1998 | EP0885215A1 Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
12/23/1998 | EP0885212A1 Quinoxalinediones |
12/23/1998 | EP0885210A1 Tricyclic compounds, their production and use |
12/23/1998 | EP0885204A1 Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
12/23/1998 | EP0885199A1 Kappa agonist compounds and pharmaceutical formulations thereof |
12/23/1998 | EP0885196A1 Chinoline-2-(1h)-ones |
12/23/1998 | EP0885192A1 Dihydropyridine-, pyridine-, benzopyran- one- and triazoloquinazoline derivative, their preparation and their use as adenosine receptor antagonists |
12/23/1998 | EP0885188A1 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors |
12/23/1998 | EP0885013A1 New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses |
12/23/1998 | EP0885004A1 Use of 4-phenyl-3,6-dihydro-2h-pyridyl derivatives as nmda receptor subtype blockers |
12/23/1998 | EP0714300B1 Methods for modulating the human sexual response |
12/23/1998 | EP0701546B1 Aromatic acetylcholinesterase inhibitors |
12/23/1998 | CN1202891A New quinoxalindione derivatives, their preparation and use in medicaments |
12/23/1998 | CN1202886A 3-spiro-indolin-2-one derivatives, its preparing method and its medicinal compounds |
12/23/1998 | CN1202822A Use of a THF alpha antagonist for treating neurogenic skin redness |
12/23/1998 | CN1041309C Method for preparing piperidine derivatives |
12/23/1998 | CA2430623A1 Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives |
12/23/1998 | CA2294589A1 Composition for controlling mood disorders in healthy individuals |
12/23/1998 | CA2294569A1 Secreted proteins and polynucleotides encoding them |
12/23/1998 | CA2294379A1 3-benzylpiperidine |
12/23/1998 | CA2294281A1 Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine |
12/23/1998 | CA2294137A1 Novel aryloxy substituted pyrimidine imidazole compounds |
12/23/1998 | CA2294011A1 Use of draflazine-analogues for treating pain |
12/23/1998 | CA2292883A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists |
12/23/1998 | CA2289100A1 Quinoline derivatives as pde iv and/or tnf inhibitors |
12/22/1998 | US5852056 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
12/22/1998 | US5852055 Pharmaceutical compositions comprising paracetamol and L-cysteine or a precursor thereof |
12/22/1998 | US5852053 Use of 2-4-amino-4-(4-fluorobenzylamino) (-1-ethoxy-carbonylaminobenzene for the prophylaxis and treatment of the neurodegenerative disorders |
12/22/1998 | US5852052 Treatment of lyso paf-mediated mental or neuronal disorders with lyso paf or paf antagonists and procedure for determining their efficacy |
12/22/1998 | US5852049 Aromatic ethers derived from indoles which are useful as medicaments |
12/22/1998 | US5852040 Neuroprotective 3,4-dihydro-2(1H)-quinolone compounds |
12/22/1998 | US5852037 Method for treating anxiety |
12/22/1998 | US5852031 2,7-substituted octahydro-1H-pyrido 1,2-a!pyrazine derivatives |
12/22/1998 | US5852022 Antipsychotic agents, composition and method of use |
12/22/1998 | US5852021 Polymorph B of 1-(diphenylmethyl)-4- 3-(2-phenyl-1,3-dioxolan-2-YL) propyl! piperazine |
12/22/1998 | US5852020 Nefazodone: use in treating post traumatic stress disorder |
12/22/1998 | US5852017 2,3(1H,4H)-quinoxalinediones |
12/22/1998 | US5852016 Quinoxaline derivatives useful in therapy |
12/22/1998 | US5852007 Cysteine and serine protease inhibitors containing D-amino acid at the P2 position, methods of making same, and methods of using same |
12/22/1998 | US5851996 Materials and methods for treatment of plaquing diseases |
12/22/1998 | US5851809 Tryptophanyl tRNA Synthetase polynucleotides of Streptococcus |
12/22/1998 | US5851786 Product and process to regulate actin polymerization |
12/18/1998 | CA2239605A1 Novel g-protein coupled receptor (h7tba62) |
12/17/1998 | WO1998056820A1 Hm74a receptor |
12/17/1998 | WO1998056793A1 3-substituted pyrido [3',4':4,5] thieno [2,3-d] pyrimidine derivatives, and production and use of the same |
12/17/1998 | WO1998056792A1 3-substituted 3,4 dihydro-thieno[2, 3-d]pyrimidine derivatives and production and use of the same |
12/17/1998 | WO1998056787A1 4-Phenylpiperidine compounds |
12/17/1998 | WO1998056786A1 2-aminoalkylaminoquinolines as dopamine d4 ligands |
12/17/1998 | WO1998056773A1 Crystal modification of 1-(2,6-difluorobenzyl)-1h-1,2,3-triazole-4-carboxamide and its use as antiepileptic |
12/17/1998 | WO1998056772A1 Crystal modification of 1-(2,6-difluorobenzyl)-1h-1,2,3--triazole-4-carboxamide and its use as antiepileptic |
12/17/1998 | WO1998056426A1 Controlled release microencapsulated ngf formulation |
12/17/1998 | WO1998056404A1 Cns neuroregenerative compositions and methods of use |
12/17/1998 | WO1998056383A1 Pharmaceutical compositions containing cinchonine dichlorhydrate |
12/17/1998 | WO1998056377A1 Novel pyrazole and pyrazoline substituted compounds |
12/17/1998 | WO1998051325A3 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods |
12/17/1998 | WO1998047917A3 A purified 20 kda presenilin 2 c-terminal fragment and methods of screening for compounds that inhibit proteolysis of presenilin 2 |
12/17/1998 | WO1998038983A3 Swallow tablet comprising paracetamol |
12/17/1998 | DE19724980A1 3-Substituierte 3,4-Dihydro-thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung 3-substituted 3,4-dihydro-thieno [2,3-d] pyrimidine derivatives, their preparation and use |
12/17/1998 | DE19724979A1 3-substituierte Pyrido [3,4,5]thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung 3-substituted pyrido [3,4,5] thieno [2,3-d] pyrimidine derivatives, their preparation and use |
12/17/1998 | CA2295704A1 Pharmaceutical compositions containing cinchonine dichlorhydrate |
12/17/1998 | CA2294057A1 Novel pyrazole and pyrazoline substituted compounds |
12/17/1998 | CA2293816A1 3-substituted 3,4 dihydro-thieno[2, 3-d]pyrimidine derivatives and production and use of the same |
12/17/1998 | CA2293492A1 Cns neuroregenerative compositions and methods of use |
12/17/1998 | CA2293480A1 2-aminoalkylaminoquinolines as dopamine d4 ligands |
12/17/1998 | CA2293440A1 3-substituted pyrido [3',4':4,5] thieno [2,3-d] pyrimidine derivatives, and production and use of the same |
12/17/1998 | CA2240005A1 Peptides acting as agonists and inhibitors of amyloid formation and cytotoxicity for therapeutic use with alzeheimer's disease, type ii diabetes mellitus and spongiform encephalopathies |
12/16/1998 | EP0884387A2 Human 7-transmembrane receptor HLWAR77 |
12/16/1998 | EP0884386A1 Sodium channel receptor |
12/16/1998 | EP0884319A2 [1,3]oxazino[3,2-A]indole derivative |
12/16/1998 | EP0884316A1 Quinazoline-4-one AMPA antagonists |
12/16/1998 | EP0884310A1 Quinazolin-4-one ampa antagonists |
12/16/1998 | EP0883619A1 Morphine and diamorphine salts of anionic non-narcotic analgesics of the substituted carboxylic acid type |
12/16/1998 | EP0883609A1 Selective d1 dopamine receptor agonists and partial agonists/antagonists |
12/16/1998 | EP0883608A1 Optical resolution of methylphenidate by 0,0'-bisaroyl tartaric acids |
12/16/1998 | EP0883599A1 Aminotetralin derivatives and compositions and method of use thereof |
12/16/1998 | EP0854726B1 Stable extract of hypericum perforatum l., process for preparing the same and pharmaceutical compositions |
12/16/1998 | EP0724572B1 Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands |
12/16/1998 | EP0690842B1 4-arylisoindole analgesics |
12/16/1998 | EP0592453B1 Aminoalkyl-substituted 2-amino-1,3,4-thiadiazoles, their preparation and their use |
12/16/1998 | EP0532752B1 Compound tan-1251, its derivatives, their production and use |
12/16/1998 | CN1202170A Quinoline derivatives as type 1V phosphodiesterase inhibitors |
12/16/1998 | CN1202164A Diarylalkenylamine derivatives |
12/16/1998 | CN1202151A Sulfur containing di-tert-butylphenol compounds useful as anti-inflammatory agents |
12/16/1998 | CN1202111A Use of epinastine in the treatment of pain |
12/16/1998 | CN1202104A Methods and compositions for stimulating neurite growth |
12/16/1998 | CN1202103A Excitatory amino acid receptor antagonists |
12/16/1998 | CN1201691A Medicine for curing encephalatrophy and preparation thereof |
12/16/1998 | CN1041203C Preparation of pyrazolopyridine compound |